KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 16.5% | 12.4% | 14.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 50.6% | 45.7% | 44.3% | 43.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -126.2% | -112.8% | -275.1% | -119.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -145.3% | -133.3% | -302.1% | -142.5% |
| EPS Diluted | -0.64 | -0.5 | -2.21 | -0.5 |
| % Growth | -28% | 77.4% | -342% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |